141 related articles for article (PubMed ID: 1562118)
1. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
Kato K
Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
[TBL] [Abstract][Full Text] [Related]
3. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
4. [Current role of amiodarone in antiarrhythmic therapy].
Sohns C; Zabel M
Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):239-43. PubMed ID: 21104260
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Podrid PJ; Lown B
Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Lubbe WF; Mercer CJ; Roche AH; Lowe JB
N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A
Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.
Fogoros RN; Anderson KP; Winkle RA; Swerdlow CD; Mason JW
Circulation; 1983 Jul; 68(1):88-94. PubMed ID: 6851057
[TBL] [Abstract][Full Text] [Related]
14. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
Russo AM; Beauregard LM; Waxman HL
Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
16. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
Lavery D; Saksena S
Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
[TBL] [Abstract][Full Text] [Related]
17. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
Myers M; Peter T; Weiss D; Nalos PC; Gang ES; Oseran DS; Mandel WJ
Am Heart J; 1990 Jan; 119(1):8-14. PubMed ID: 2296879
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
[TBL] [Abstract][Full Text] [Related]
19. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
[TBL] [Abstract][Full Text] [Related]
20. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
